메뉴 건너뛰기




Volumn 42, Issue 7, 2002, Pages 680-688

Comparison of therapeutic gain with therapeutic ratio for the assessment of selective 5HT1B/1D agonist efficacy in migraine

Author keywords

Efficacy; Meta analysis; Migraine; Selective 5HT1B 1D agonists

Indexed keywords

ALMOTRIPTAN; FROVATRIPTAN; NARATRIPTAN; RIZATRIPTAN; SEROTONIN 1B AGONIST; SEROTONIN 1D AGONIST; SUMATRIPTAN; ZOLMITRIPTAN;

EID: 0036656619     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2002.02158.x     Document Type: Review
Times cited : (8)

References (19)
  • 1
    • 0031760112 scopus 로고    scopus 로고
    • Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: A systematic review based on number needed to treat
    • (1998) Cephalalgia , vol.18 , pp. 532-538
    • Tfelt-Hansen, P.1
  • 3
    • 0028908929 scopus 로고
    • The number needed to treat: A clinically useful measure of treatment effect
    • see also correction Br Med J. 1995;310:1056
    • (1995) Br Med J , vol.310 , pp. 452-454
    • Cook, R.J.1    Sackett, D.L.2
  • 8
    • 0000273765 scopus 로고    scopus 로고
    • Comparison of triptan efficacy: Examination of response ratios and therapeutic gain
    • (2001) Cephalalgia , vol.21 , pp. 441-442
    • Winner, P.1
  • 17
    • 0000273765 scopus 로고    scopus 로고
    • Comparison of triptan efficacy: Examination of response ratios and therapeutic gain
    • (2001) Cephalalgia , vol.21 , pp. 441-442
    • Winner, P.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.